Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age

ERDİL N., Kaynak M., Donmez K., DİŞLİ O. M., BATTALOĞLU B.

REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, cilt.29, sa.4, ss.581-587, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5935/1678-9741.20140078
  • Dergi Adı: REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.581-587
  • Anahtar Kelimeler: Coronary Artery Bypass, Atrial Fibrillation, Anti-Arrhythmia Agents, Drug Therapy, ARTERY BYPASS-SURGERY, CARDIAC-SURGERY, GRAFT-SURGERY, BETA-BLOCKER, RISK, METAANALYSIS, ATENOLOL, HYPERTENSION, ARRHYTHMIAS, PREDICTORS
  • İnönü Üniversitesi Adresli: Evet

Özet

Objective: Postoperative atrial fibrillation is a common complication after cardiac surgery, with an incidence as high as 20-50%. Increased age is associated with a significant increase in postoperative atrial fibrillation risk. This common complication is associated with higher morbidity and mortality rates. The aim of this study was to assess the efficacy of nebivolol in preventing atrial fibrillation following coronary artery bypass surgery in patients over 60 years of age.